Background The beneficial effects of a cardiac resynchronization defibrillator (CRT-D) in
patients with heart failure, low left ventricular ejection fraction (LVEF), and wide QRS have …

Introduction Cardiac resynchronization defibrillator (CRT‐D) as primary prevention is known
to reduce mortality. At the time of replacement, higher age and comorbidities may attenuate …

Background Cardiac resynchronization therapy (CRT) reduces morbidity and mortality in
selected heart failure patients, but decision-making regarding selection of CRT-defibrillator …

Aims Comorbidity, such as myocardial infarction, diabetes, and renal failure, plays a pivotal
role in the prognosis of a patient with arrhythmias. However, data on the prognostic impact of …

Aims Mortality after cardiac resynchronization therapy (CRT) is difficult to predict. We sought
to design and validate a simple prognostic score for patients implanted with CRT, based on …

Abstract Aims The Goldenberg risk score, comprising five clinical risk factors (New York
Heart Association class> 2, atrial fibrillation, QRS duration> 120 ms, age> 70 years, and …

Aims The current study includes all consecutive patients with advanced heart failure and
cardiac resynchronization therapy (CRT) with an implantable cardioverter defibrillator (ICD) …

Background Risk-benefit for cardiac resynchronisation therapy (CRT) defibrillator (CRT-D)
over CRT pacemaker remains a matter of debate. We aimed to identify patients with a poor …

Background Patients with heart failure having a low expected probability of arrhythmic death
may not benefit from implantable cardioverter defibrillators (ICDs). Objective The objective …

INTRODUCTION: Cardiac resynchronization therapy (CRT) improves functional status and
reduces heart failure (HF) hospitalizations. Multicenter studies with long term follow-up have …